Compare AdaptHealth Corp (AHCO) vs Roblox Corp (RBLX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Roblox Corp — how do they compare? AdaptHealth Corp trades at $10.04 (market cap $1.38B), while Roblox Corp trades at $54.31 (market cap $40.60B). The key difference: Roblox Corp is far larger — about 29.4× AdaptHealth Corp's market cap, and AdaptHealth Corp is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | RBLX | |
|---|---|---|
Market Cap | $1.38B | $40.60B |
Sector | Health | Media |
52-Week High | $13.38 | $141.56 |
52-Week Low | $8.68 | $41.30 |
Enterprise Value | $3.33B | $39.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Roblox trades at $56.70, up 2.31% with strong technical momentum and bullish moving average signals. The company shows impressive revenue growth to $4.89 billion in 2025 and positive operating cash flow of $1.80 billion, though it remains unprofitable with a -20.69% net margin. Recent earnings beats and analyst consensus of $64.07 price target suggest upside potential, but multiple class action lawsuits filed in July 2026 create significant legal overhang.
While Roblox demonstrates strong user monetization and cash generation, profitability challenges and legal risks weigh on investor sentiment. The stock offers growth exposure but requires careful risk management given the negative earnings profile and ongoing litigation. Analyst optimism appears tempered by fundamental weaknesses and recent legal developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
